Update points for the 2022 edition of the European Association for the Study of Liver Diseases Clinical Practice Guidelines for the Management of Hepatic Encephalopathy and comparison with China’s 2018 edition guidelines
10.3760/cma.j.cn501113-20221111-00560
- VernacularTitle:2022年《欧洲肝病学会肝性脑病管理临床实践指南》更新要点及其与我国2018版指南的比较
- Author:
Tingyu ZHANG
1
;
Xin SUN
;
Yuhao YAO
;
Qian JIN
;
Danan GAN
;
Yongan YE
;
Xiaoke LI
Author Information
1. 北京中医药大学东直门医院，北京 100700
- Keywords:
Hepatic encephalopathy;
Diagnosis;
Therapeutics;
Guide interpretation
- From:
Chinese Journal of Hepatology
2023;31(9):921-927
- CountryChina
- Language:Chinese
-
Abstract:
The European Association for the Study of Liver Diseases issued the "Clinical Practice Guidelines for the Management of Hepatic Encephalopathy" in 2022, which included recommendations for clinical diagnosis, assessment, treatment, management, and prevention. The Society’s "Hepatic Encephalopathy Clinical Practice Guidelines in Chronic Liver Disease," which was last published in 2014, and the "Guidelines for the Diagnosis and Treatment of Hepatic Encephalopathy in Cirrhosis," which the Chinese Society of Hepatology, Chinese Medical Association, released in 2018, have certain differences and updates in terms of comparison to terminology, grading and classification, diagnosis, clinical evaluation and treatment, management, and prevention. Herein, the updated points of this guideline and the differences between it and our nation’s guidelines are summarized in order to refine and understand the guiding role of the new version of the guideline for the clinical treatment of hepatic encephalopathy and provide aid for standardizing clinical diagnosis and treatment.
